Reported by 2 sources

The short version

  • Karl Deisseroth, Peter Hegemann, and Georg Nagel are recognized for establishing optogenetics, a method that allows scientists to activate or silence specific neurons using light.
  • The technique relies on channelrhodopsin proteins discovered in green algae, which were genetically inserted into animal cells to make them responsive to optical stimulation.
  • This innovation has enabled researchers to map causal links between neural activity and behaviors, offering new avenues for understanding conditions like Alzheimer's disease and depression.

The Nobel Committee awarded the 2026 Prize in Physiology or Medicine to three scientists who developed a revolutionary tool for neuroscience. Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University of Berlin, and Georg Nagel of the University of Würzburg were honored for their foundational work in optogenetics. This technique allows researchers to precisely control nerve cells with light, providing unprecedented insight into how the brain generates behavior, emotion, and memory.

The central challenge in neuroscience has long been establishing cause and effect within the complex network of nearly 90 billion neurons. Traditional methods often struggled to isolate specific neural circuits responsible for particular actions or thoughts. The laureates’ work created a biological switch that can turn targeted neurons on or off with high precision. This capability has transformed the field by allowing scientists to observe direct connections between cellular activity and observable outcomes in live animals.

News Journal

The origins of this technology trace back to the early 2000s, when Hegemann and Nagel identified a light-sensitive protein called channelrhodopsin in Chlamydomonas reinhardtii, a species of green algae. These single-celled organisms use the protein to sense and move toward light. When exposed to blue light, channelrhodopsin opens channels on the cell surface, allowing ions to flow in and generate electrical impulses. Hegemann and Nagel demonstrated that inserting the gene for this protein into other organisms, such as human kidney cells or hamster cells, could confer similar light sensitivity.

Deisseroth, who was establishing his laboratory at Stanford around the same time, sought a reliable way to trigger electrical signals in specific neurons. He learned of Hegemann and Nagel’s discovery and obtained the DNA encoding channelrhodopsin. By introducing this genetic material into rat neurons cultured in dishes, Deisseroth confirmed that these cells responded to blue light. He described this approach as high-risk but ultimately the most effective method he tested, noting that it required years of development to mature into a robust technology.

The team subsequently refined the technique for use in living animals. They utilized ultrathin, flexible optical fibers to deliver light directly to altered brain cells. Early experiments demonstrated the power of this method by controlling the movement of mouse whiskers through optical stimulation. Since those initial successes, researchers have expanded the toolkit to include proteins sensitive to various colors of light, allowing for more complex manipulation of neural circuits.

The implications of optogenetics extend beyond basic research into potential clinical applications. Scientists are investigating how this precision tool can elucidate the mechanisms behind disorders such as depression, schizophrenia, and Alzheimer’s disease. By identifying which neural pathways malfunction in these conditions, researchers hope to develop targeted therapies. Some studies are even exploring whether optogenetics could restore vision in patients with retinitis pigmentosa, a genetic condition that causes the gradual death of light-sensitive cells in the retina.

Colleagues in the scientific community have long anticipated this recognition for the pioneers of the field. Many noted that Hegemann, in particular, had been overlooked despite his critical contributions to understanding mechanistic processes at the cellular level. The award underscores the importance of interdisciplinary collaboration, combining biophysics and neuroscience to create tools that redefine experimental possibilities.

Each laureate will share a prize of 12 million Swedish kronor, approximately $1.2 million. The announcement marks the beginning of this year’s Nobel Prize series, with awards in other categories expected to follow in the coming days. The recognition of optogenetics highlights a shift toward more precise, causal methods in biological research, moving beyond correlation to direct manipulation of living systems.

As the technique continues to evolve, it promises to further unravel the mysteries of the brain’s vast circuits. By enabling scientists to probe the neural basis of perception and decision-making with laser-like precision, optogenetics has opened a new era in understanding human cognition and disease. The work of Deisseroth, Hegemann, and Nagel stands as a testament to the power of innovative tools in driving scientific discovery.

Sources behind this briefing

Go to the original reporting

  • Smithsonian Magazine↗Trio of Scientists Wins Medicine Nobel for a Method to Turn Nerve Cells On and Off With Light, Helping to Unravel the Brain's Mysteries
  • The Guardian US↗Nobel prize in medicine 2026: unlocking the mysteries of the brain